Brind.

Thomas Schall purchased shares of Immuneering on September 5, 2025.

1 report, 1 independent Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Thomas Schall purchased shares of Immuneering on September 5, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Pleasing Signs As A Number Of Insiders Buy Immuneering Stock It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Immuneering Co